NMPA Approval

Brentuximab Vedotin for Injection

Approval Number

国药准字SJ20200008

Registration Date

February 7, 2025

Previous Approval Numbers

S20200008

Drug Information

Generic Name

注射用维布妥昔单抗

Trade Name

安适利

Dosage Form

注射剂

Strength

50mg

Drug Type

生物制品

Registration Date

February 7, 2025

Expiry Date

February 6, 2030

Company Address

Delta Park 45, 2665 Vallensbaek Strand, Denmark

Company Address

Via Appia Km. 65, 561, Latina Scalo (LT), 04013，Italy

Empowering clinical research with data-driven insights and AI-powered tools.